Curasight A/S presents at Sedermeradagen in Copenhagen 7 December 2021

December 6, 2021

Regulatory

Curasight A/S CEO Ulrich Krasilnikoff and CSO professor Andreas Kjær will present the company and its future plans at Sedermeradagen in Copenhagen 7 December 2021.

The conference will be a live event with physical presentation at Villa Copenhagen. The conference will not be webcasted live.

For more information and registration– please click here

For more information regarding Curasight, please contact:

Ulrich Krasilnikoff, CEO

Phone: +45 22 83 01 60

E-mail: uk@curasight.com

www.curasight.com

Downloads

Press Release 06-12-2021_Sedermeradagen

Curasight is a clinical development company based in Copenhagen, Denmark. The company is a pioneer in the field of exploiting a novel Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (“uPAR”). The technology is expected to improve diagnosis and risk stratification in multiple cancer types.